Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Add To Watchlist

OTCQX:MRVFF - Post Discussion

Nuvo Pharmaceuticals Inc > Resultz

View:

Post by ValueCap on Nov 05, 2019 6:49pm

Resultz

Nuvo completed the tech transfer and the Varennes facility is set up to manufacture Resultz to its distributors, which adds one layer of value.

The team apparently is still incentivized to sign a US distributor by year end.

They are hoping for a multiple in the teens of revenues.

Resultz typically dominates a market that it’s in.

Here’s an estimate for the US lice market - 440 million by 2024.

If you include an upfront payment, licensing revenue royalties, and sales from manufacturing at Varennes, that’s a good number to the bottom line.

I get that the team is incentivized for year end and have been in talks with a potential distributor. I hope they make it happen.

https://www.marketwatch.com/press-release/head-lice-infestation-drug-market-size-to-surge-at-43-cagr-poised-to-touch-usd-440-million-by-2024-2019-05-10

186